Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2005;111:1448-1454
doi: 10.1161/01.CIR.0000158483.13093.9D
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dandona, P.
Right arrow Articles by Garg, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dandona, P.
Right arrow Articles by Garg, R.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Metabolic Syndrome
Related Collections
Right arrow Obesity
Right arrow Risk Factors
Right arrow Glucose intolerance

(Circulation. 2005;111:1448-1454.)
© 2005 American Heart Association, Inc.


Contemporary Reviews in Cardiovascular Medicine

Metabolic Syndrome

A Comprehensive Perspective Based on Interactions Between Obesity, Diabetes, and Inflammation

Paresh Dandona, MD, PhD; Ahmad Aljada, PhD; Ajay Chaudhuri, MD; Priya Mohanty, MD; Rajesh Garg, MD

From the Division of Endocrinology, Diabetes, and Metabolism, State University of New York at Buffalo, and Kaleida Health, Buffalo, NY.

Correspondence to Paresh Dandona, MD, PhD, Director, Diabetes-Endocrinology Center of Western New York, Professor of Medicine, State University of New York at Buffalo, 3 Gates Circle, Buffalo, NY 14209. E-mail pdandona@kaleidahealth.org

Received June 28, 2004; revision received August 26, 2004; accepted October 15, 2004.


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 


*    Introduction
 
The original description of the metabolic syndrome by Reaven1 consisted of obesity, insulin resistance, hypertension, impaired glucose tolerance or diabetes, hyperinsulinemia and dyslipidemia characterized by elevated triglyceride, and low HDL concentrations. All of the features described above are risk factors for atherosclerosis, and thus, metabolic syndrome constituted a significant risk for coronary heart disease2–5 (Table). The features of obesity/overweight and insulin resistance also provided a significant risk for developing type 2 diabetes.5,6 The risks for coronary heart disease and diabetes with metabolic syndrome are greater than those for simple obesity alone, and therefore, an understanding of the pathogenesis and through it, a rational approach to its therapy are of prime importance.


View this table:
[in this window]
[in a new window]
 
Classic Biological Effects of Insulin and Classic Metabolic Syndrome Based on Resistance to the Metabolic Effects of Insulin

As our understanding of the action of insulin evolves to comprehensively include the recent discoveries,7 we can better see that insulin resistance is the basis of most if not all of the features of this syndrome. The original conceptualization of this syndrome was on the basis of resistance to the metabolic actions of insulin. Thus, hyperinsulinemia, glucose intolerance, type 2 diabetes, hypertriglyceridemia, and low HDL concentrations could be accounted for by resistance to the actions of insulin on carbohydrate and lipid metabolism. Although the features described above would to some extent explain the atherogenesis, Reaven has maintained that hyperinsulinemia itself contributes to atherogenicity, and thus, insulin is atherogenic, leading to the coronary heart disease and cerebrovascular disease associated with . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
J. Nutr.Home page
T. Tholstrup, M. Raff, E. M. Straarup, P. Lund, S. Basu, and J. M. Bruun
An Oil Mixture with Trans-10, Cis-12 Conjugated Linoleic Acid Increases Markers of Inflammation and in Vivo Lipid Peroxidation Compared with Cis-9, Trans-11 Conjugated Linoleic Acid in Postmenopausal Women
J. Nutr., August 1, 2008; 138(8): 1445 - 1451.
[Abstract] [Full Text] [PDF]


Home page
CLIN APPL THROMB HEMOSTHome page
G. de Larranaga, S. P. Wingeyer, M. Graffigna, S. Belli, K. Bendezu, S. Alvarez, O. Levalle, and H. Fainboim
Plasma Plasminogen Activator Inhibitor-1 Levels and Nonalcoholic Fatty Liver in Individuals With Features of Metabolic Syndrome
Clinical and Applied Thrombosis/Hemostasis, July 1, 2008; 14(3): 319 - 324.
[Abstract] [PDF]


Home page
Am. J. Clin. Nutr.Home page
P. Kallio, M. Kolehmainen, D. E Laaksonen, L. Pulkkinen, M. Atalay, H. Mykkanen, M. Uusitupa, K. Poutanen, and L. Niskanen
Inflammation markers are modulated by responses to diets differing in postprandial insulin responses in individuals with the metabolic syndrome
Am. J. Clinical Nutrition, May 1, 2008; 87(5): 1497 - 1503.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Sasaki, N. Suzuki, R. Kent Jr., N. Kawashima, J. Takeda, and P. Stashenko
T Cell Response Mediated by Myeloid Cell-Derived IL-12 Is Responsible for Porphyromonas gingivalis-Induced Periodontitis in IL-10-Deficient Mice
J. Immunol., May 1, 2008; 180(9): 6193 - 6198.
[Abstract] [Full Text] [PDF]


Home page
J AndrolHome page
S. S. Kasturi, J. Tannir, and R. E. Brannigan
The Metabolic Syndrome and Male Infertility
J Androl, May 1, 2008; 29(3): 251 - 259.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
I. Russo, P. Del Mese, G. Doronzo, L. Mattiello, M. Viretto, A. Bosia, G. Anfossi, and M. Trovati
Resistance to the Nitric Oxide/Cyclic Guanosine 5'-Monophosphate/Protein Kinase G Pathway in Vascular Smooth Muscle Cells from the Obese Zucker Rat, a Classical Animal Model of Insulin Resistance: Role of Oxidative Stress
Endocrinology, April 1, 2008; 149(4): 1480 - 1489.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
H.-C. Yeh, N. M. Punjabi, N.-Y. Wang, J. S. Pankow, B. B. Duncan, C. E. Cox, E. Selvin, and F. L. Brancati
Cross-Sectional and Prospective Study of Lung Function in Adults With Type 2 Diabetes: The Atherosclerosis Risk in Communities (ARIC) Study
Diabetes Care, April 1, 2008; 31(4): 741 - 746.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
S-G Ahn, H-S Lim, D-Y Joe, S-J Kang, B-J Choi, S-Y Choi, M-H Yoon, G-S Hwang, S-J Tahk, and J-H Shin
Relationship of epicardial adipose tissue by echocardiography to coronary artery disease
Heart, March 1, 2008; 94(3): e7 - e7.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
G. P. Van Guilder, G. L. Hoetzer, J. J. Greiner, B. L. Stauffer, and C. A. DeSouza
Metabolic syndrome and endothelial fibrinolytic capacity in obese adults
Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2008; 294(1): R39 - R44.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
L. Bouchard, M.-C. Vohl, Y. Deshaies, C. Rheaume, M. Daris, and A. Tchernof
Visceral adipose tissue zinc finger protein 36 mRNA levels are correlated with insulin, insulin resistance index, and adiponectinemia in women
Eur. J. Endocrinol., October 1, 2007; 157(4): 451 - 457.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
M. G. Dik, C. Jonker, H. C. Comijs, D. J.H. Deeg, A. Kok, K. Yaffe, and B. W. Penninx
Contribution of Metabolic Syndrome Components to Cognition in Older Individuals
Diabetes Care, October 1, 2007; 30(10): 2655 - 2660.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
A. W Hsing, L. C Sakoda, and S. C Chua Jr
Obesity, metabolic syndrome, and prostate cancer
Am. J. Clinical Nutrition, September 1, 2007; 86(3): 843S - 857S.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
P. Barter, Y. R. McPherson, K. Song, Y. A. Kesaniemi, R. Mahley, G. Waeber, T. Bersot, V. Mooser, D. Waterworth, and S. M. Grundy
Serum Insulin and Inflammatory Markers in Overweight Individuals with and without Dyslipidemia
J. Clin. Endocrinol. Metab., June 1, 2007; 92(6): 2041 - 2045.
[Abstract] [Full Text] [PDF]


Home page
Epidemiol RevHome page
S. Musaad and E. N. Haynes
Biomarkers of Obesity and Subsequent Cardiovascular Events
Epidemiol. Rev., May 10, 2007; (2007) mxm005v1.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
I. M. Wahba and R. H. Mak
Obesity and Obesity-Initiated Metabolic Syndrome: Mechanistic Links to Chronic Kidney Disease
Clin. J. Am. Soc. Nephrol., May 1, 2007; 2(3): 550 - 562.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
Y. Song, T. Y Li, R. M van Dam, J. E Manson, and F. B Hu
Magnesium intake and plasma concentrations of markers of systemic inflammation and endothelial dysfunction in women
Am. J. Clinical Nutrition, April 1, 2007; 85(4): 1068 - 1074.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
C. Popa, M. G. Netea, P. L. C. M. van Riel, J. W. M. van der Meer, and A. F. H. Stalenhoef
The role of TNF-{alpha} in chronic inflammatory conditions, intermediary metabolism, and cardiovascular risk
J. Lipid Res., April 1, 2007; 48(4): 751 - 762.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Coll. Nutr.Home page
J. W. Rankin and A. D. Turpyn
Low Carbohydrate, High Fat Diet Increases C-Reactive Protein during Weight Loss
J. Am. Coll. Nutr., April 1, 2007; 26(2): 163 - 169.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
A. Esmaillzadeh, M. Kimiagar, Y. Mehrabi, L. Azadbakht, F. B. Hu, and W. C. Willett
Dietary Patterns and Markers of Systemic Inflammation among Iranian Women
J. Nutr., April 1, 2007; 137(4): 992 - 998.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
D. E. King, B. M. Egan, R. F. Woolson, A. G. Mainous III, Y. Al-Solaiman, and A. Jesri
Effect of a High-Fiber Diet vs a Fiber-Supplemented Diet on C-Reactive Protein Level
Arch Intern Med, March 12, 2007; 167(5): 502 - 506.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. C. Frisbee, J. B. Samora, J. Peterson, and R. Bryner
Exercise training blunts microvascular rarefaction in the metabolic syndrome
Am J Physiol Heart Circ Physiol, November 1, 2006; 291(5): H2483 - H2492.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. J. Ryan, G. R. McLemore Jr, and S. T. Hendrix
Insulin Resistance and Obesity in a Mouse Model of Systemic Lupus Erythematosus
Hypertension, November 1, 2006; 48(5): 988 - 993.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
E. Lopez-Garcia, R. M van Dam, L. Qi, and F. B Hu
Coffee consumption and markers of inflammation and endothelial dysfunction in healthy and diabetic women.
Am. J. Clinical Nutrition, October 1, 2006; 84(4): 888 - 893.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J.-M. Ategbo, O. Grissa, A. Yessoufou, A. Hichami, K. L. Dramane, K. Moutairou, A. Miled, A. Grissa, M. Jerbi, Z. Tabka, et al.
Modulation of Adipokines and Cytokines in Gestational Diabetes and Macrosomia
J. Clin. Endocrinol. Metab., October 1, 2006; 91(10): 4137 - 4143.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
K. M. Beard, H. Lu, K. Ho, and I. G. Fantus
Bradykinin Augments Insulin-Stimulated Glucose Transport in Rat Adipocytes via Endothelial Nitric Oxide Synthase-Mediated Inhibition of Jun NH2-Terminal Kinase.
Diabetes, October 1, 2006; 55(10): 2678 - 2687.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. Imagawa, S. Fujii, J. Dong, T. Furumoto, T. Kaneko, T. Zaman, Y. Satoh, H. Tsutsui, and B. E Sobel
Hepatocyte Growth Factor Regulates E Box-Dependent Plasminogen Activator Inhibitor Type 1 Gene Expression in HepG2 Liver Cells
Arterioscler. Thromb. Vasc. Biol., October 1, 2006; 26(10): 2407 - 2413.
[Abstract] [Full Text] [PDF]


Home page
SEMIN CARDIOTHORAC VASC ANESTHHome page
P. A. van Zwieten and G. Mancia
Background and treatment of metabolic syndrome: a therapeutic challenge.
Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 2006; 10(3): 206 - 214.
[Abstract] [PDF]


Home page
Am. J. Clin. Nutr.Home page
B. E Millen, M. J Pencina, R. W Kimokoti, L. Zhu, J. B Meigs, J. M Ordovas, and R. B D'Agostino
Nutritional risk and the metabolic syndrome in women: opportunities for preventive intervention from the Framingham Nutrition Study.
Am. J. Clinical Nutrition, August 1, 2006; 84(2): 434 - 441.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
K. Esposito, M. Ciotola, D. Carleo, B. Schisano, F. Saccomanno, F. C. Sasso, D. Cozzolino, R. Assaloni, D. Merante, A. Ceriello, et al.
Effect of Rosiglitazone on Endothelial Function and Inflammatory Markers in Patients With the Metabolic Syndrome
Diabetes Care, May 1, 2006; 29(5): 1071 - 1076.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. H.E.M. Klerkx, K. E. Harchaoui, W. A. van der Steeg, S. M. Boekholdt, E. S.G. Stroes, J. J.P. Kastelein, and J. A. Kuivenhoven
Cholesteryl Ester Transfer Protein (CETP) Inhibition Beyond Raising High-Density Lipoprotein Cholesterol Levels: Pathways by Which Modulation of CETP Activity May Alter Atherogenesis
Arterioscler. Thromb. Vasc. Biol., April 1, 2006; 26(4): 706 - 715.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
T. H. Schindler, J. Cardenas, J. O. Prior, A. D. Facta, M. C. Kreissl, X.-L. Zhang, J. Sayre, M. Dahlbom, J. Licinio, and H. R. Schelbert
Relationship Between Increasing Body Weight, Insulin Resistance, Inflammation, Adipocytokine Leptin, and Coronary Circulatory Function
J. Am. Coll. Cardiol., March 21, 2006; 47(6): 1188 - 1195.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. Taleb, R. Cancello, C. Poitou, C. Rouault, P. Sellam, P. Levy, J.-L. Bouillot, C. Coussieu, A. Basdevant, M. Guerre-Millo, et al.
Weight Loss Reduces Adipose Tissue Cathepsin S and Its Circulating Levels in Morbidly Obese Women
J. Clin. Endocrinol. Metab., March 1, 2006; 91(3): 1042 - 1047.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
T. Nakagawa, H. Hu, S. Zharikov, K. R. Tuttle, R. A. Short, O. Glushakova, X. Ouyang, D. I. Feig, E. R. Block, J. Herrera-Acosta, et al.
A causal role for uric acid in fructose-induced metabolic syndrome
Am J Physiol Renal Physiol, March 1, 2006; 290(3): F625 - F631.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
J. M. Arbones-Mainar, M. A. Navarro, S. Acin, M. A. Guzman, C. Arnal, J. C. Surra, R. Carnicer, H. M. Roche, and J. Osada
Trans-10, cis-12- and cis-9, trans-11-Conjugated Linoleic Acid Isomers Selectively Modify HDL-Apolipoprotein Composition in Apolipoprotein E Knockout Mice
J. Nutr., February 1, 2006; 136(2): 353 - 359.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
K. Esposito and D. Giugliano
Diet and inflammation: a link to metabolic and cardiovascular diseases
Eur. Heart J., January 1, 2006; 27(1): 15 - 20.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
A. Fortuno, G. San Jose, M. U. Moreno, O. Beloqui, J. Diez, and G. Zalba
Phagocytic NADPH Oxidase Overactivity Underlies Oxidative Stress in Metabolic Syndrome
Diabetes, January 1, 2006; 55(1): 209 - 215.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
K. B. Moysich, J. A. Baker, K. J. Rodabaugh, and J. A. Villella
Regular Analgesic Use and Risk of Endometrial Cancer
Cancer Epidemiol. Biomarkers Prev., December 1, 2005; 14(12): 2923 - 2928.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Tesauro, F. Schinzari, M. Iantorno, S. Rizza, D. Melina, D. Lauro, and C. Cardillo
Ghrelin Improves Endothelial Function in Patients With Metabolic Syndrome
Circulation, November 8, 2005; 112(19): 2986 - 2992.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
H. Bruunsgaard
Physical activity and modulation of systemic low-level inflammation
J. Leukoc. Biol., October 1, 2005; 78(4): 819 - 835.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
A. T. Kraja, D. C. Rao, A. B. Weder, R. Cooper, J. D. Curb, C. L. Hanis, S. T. Turner, M. de Andrade, C. A. Hsiung, T. Quertermous, et al.
Two Major QTLs and Several Others Relate to Factors of Metabolic Syndrome in the Family Blood Pressure Program
Hypertension, October 1, 2005; 46(4): 751 - 757.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
S. M. Grundy
Point: The Metabolic Syndrome Still Lives
Clin. Chem., August 1, 2005; 51(8): 1352 - 1354.
[Full Text] [PDF]